The decision to continue, adjust, or discontinue therapy should be based on objective body composition measurements (DEXA scans, circumference measurements), achievement of fat loss goals, tolerance and side effect profile, and physician assessment of metabolic markers
Perhaps this was confirmed in one of the clinical trials taking place in Australia, where nearly 300 obese individuals experienced weight loss
AOD-9604 Regulatory Status As of June 2026, AOD-9604 is not FDA-approved for any therapeutic use
How AOD9604 Works AOD9604 mimics the way natural HGH regulates fat metabolism, but it targets lipolysis (fat breakdown) specifically, while having minimal impact on glucose regulation or protein synthesis
Apply gentle pressure with a clean alcohol pad if any bleeding occurs (typically minimal to none)